Potential of the Combination of a Systemic Enzyme Complex and Probiotics administration to Combat COVID-19: A Randomized Open Label Prospective Analysis
Journal Title: Advances in Clinical Toxicology - Year 2021, Vol 6, Issue 1
Abstract
Background: Enzymes have been used for therapeutic applications for decades owing to their anti-inflammatory and immunomodulatory effects. Probiotics are well known to reduce the incidence and severity of several health-related conditions. To our knowledge, no clinical trial has evaluated the effects of a combination of systemic enzyme and probiotic supplementation in Covid-19 patients infected with the SARSCoV-2 virus. Objective: We investigated the safety and efficacy of the health supplements ImmunoSEB (systemic enzyme complex) and ProbioSEB CSC3 (probiotic complex) as supplemental therapy in confirmed mild to moderate COVID-19 patients. Methods: A randomized, open label, 2-arm, prospective study in patients with an RT-PCR confirmed diagnosis of COVID-19 with a mild to moderate condition was conducted. The control arm (n=30) received standard of care (SOC) treatment and the test arm (n=30) received the oral supplements ImmunoSEB (500 mg/cap.) + ProbioSEB CSC3 (5 billion CFUs /cap.) for 14 days in addition to SOC. The efficacy and safety of the experimental regimen was compared with the control arm at various timepoints from days 1 to 21. Results: A significantly higher proportion of patients in the test arm showed clinical improvement on day 10 vs the controls (93.33% vs 60%; p<0.05). No adverse events were reported in the test arm at any time during the study suggesting the safety of supplementation with ImmunoSEB + ProbioSEB CSC3. Patients in the test arm also had a shorter duration of hospitalization, quicker recovery and faster reduction in CRP levels as compared to the control arm. Conclusions: The present study concludes that supplemental therapy with ImmunoSEB + ProbioSEB CSC3 accelerates clinical improvement in mild to moderate COVID-19 patients. While there is no vaccine or specific drug to completely cure SARS CoV-2 infection, the proposed supplemental therapy could be a potential tool to aid in the recovery of COVID-19 of patients.
Authors and Affiliations
Neha Shah*, Rohit Parate and Abhay Vispute
Keywords
Related Articles
- EP ID EP751772
- DOI 10.23880/act-16000205
- Views 52
- Downloads 0
Protective Effect of Protocatechuic Acid in Genotoxicity-Induced by Carbon Tetrachloride: A Preliminary Study
Carbon tetrachloride (CCl4) is commonly utilized as a solvent, a refrigerant, and a dry-cleaning agent. However, its genotoxic effect has been well documented. The present work was designed to assess the genotoxic effect...
Methyl Mercury, Adipokines, 3T3-L1 Cells and Diabetes
Diabetes is a contributor to morbidity across the globe and is often associated with obesity and metabolic syndrome. In addition to genetic and lifestyle factors, environmental factors such as metals and persistent orga...
Is Genotoxicity of Peroxisome Proliferator-Activated Receptor Agonists Due to Oxidative Stress Via Agonistic Pathways?
In order to investigate the relationship between genotoxicity and peroxisome proliferator-activated receptor (PPAR) agonistic effects, we conducted two kinds of comet assays (cellular and acellular), a micronucleus (MN)...
General and Reproductive Toxicity of 2,4-Dichlorophenoxyacetic acid (2,4-D)
The use of pesticides adversely affecting human, animal and environmental life occurs as a result of soil, air and water contamination. 2,4-Dichlorophenoxyacetic acid (2,4-D) is a selective herbicide of the phenoxyaceti...
Evaluation of Microbial Quality and Hygienic Process of Powdered Infant Formulas in the Omani Market
Substitution of breast milk with powdered infant formula (PIF) for infants is a common practice worldwide. However, since PIF is not sterile, microbial contamination from processing lines and environment is quite possibl...